SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

12 May 2025 Evaluate
Revenue showed a marginal decline at Rs. 3819.38 millions. For the quarter ended March 2025, as compared to corresponding quarter of last year.Net Profit of the company move down -70.19% to Rs. 119.11  millions from Rs. 399.59 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 333.01 millions from 601.22 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 3819.38 3926.00 -2.72 15545.35 15375.94 1.10 15545.35 15375.94 1.10
Other Income 31.42 39.86 -21.17 157.20 125.66 25.10 157.20 125.66 25.10
PBIDT 333.01 601.22 -44.61 1691.31 1743.84 -3.01 1691.31 1743.84 -3.01
Interest 37.43 7.28 414.15 71.03 35.09 102.42 71.03 35.09 102.42
PBDT 295.58 593.94 -50.23 1620.28 1708.75 -5.18 1620.28 1708.75 -5.18
Depreciation 122.54 66.88 83.22 244.42 219.00 11.61 244.42 219.00 11.61
PBT 173.04 527.06 -67.17 1375.86 1489.75 -7.64 1375.86 1489.75 -7.64
TAX 53.93 127.47 -57.69 360.10 380.40 -5.34 360.10 380.40 -5.34
Deferred Tax 47.27 -4.36 -1184.17 47.27 -4.36 -1184.17 47.27 -4.36 -1184.17
PAT 119.11 399.59 -70.19 1015.76 1109.35 -8.44 1015.76 1109.35 -8.44
Equity 1095.84 1022.27 7.20 1095.84 1022.27 7.20 1095.84 1022.27 7.20
PBIDTM(%) 8.72 15.31 -43.07 10.88 11.34 -4.07 10.88 11.34 -4.07

Morepen Laboratories Share Price

40.12 -0.06 (-0.15%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×